BRCP/ABCG2 is reportedly responsible for multi-drug resistance due to pumping drugs out of cancer cells, and GST also contributes via the detoxification and deactivation of anticancer drugs (Arévalo et al., 2017[5]; Doğanlar et al., 2020[15]). The gene discussed is ABCG2; the disease is cancer.